Clearance
pharmacologyThe rate at which the body removes a substance, usually expressed as a volume of blood or plasma cleared per unit of time. Clearance is a major factor in how long a drug's presence and effects persist.
Clearance is a measure of how efficiently the body removes a substance from the bloodstream, expressed as the volume of blood or plasma completely cleared of that substance per unit of time — typically in millilitres per minute or litres per hour. A substance with high clearance disappears quickly; one with low clearance lingers, often well beyond the period of obvious effects.
Total clearance is the combined contribution of every organ involved in elimination. The liver and kidneys do most of the work: the liver breaks the majority of drugs down through metabolic enzymes, while the kidneys filter water-soluble compounds and their metabolites into urine. Lungs, bile, and sweat contribute for a smaller subset of substances.
Clearance is one of two primary parameters — alongside volume of distribution — that set a drug's half-life. When clearance falls, half-life extends, and the substance accumulates or persists longer than a single-dose experience would suggest.
How it works · its role
Hepatic clearance depends on three things: blood flow to the liver, the fraction of drug not bound to plasma proteins (only unbound drug is available for metabolism), and the activity of the enzymes doing the work — chiefly the cytochrome P450 family. Drugs processed mainly by the liver are described as high-extraction or low-extraction depending on how completely the organ removes them on a single pass through.
Renal clearance is the net result of three competing processes: filtration at the glomerulus, active secretion into the tubule, and reabsorption back into the bloodstream. Drugs cleared primarily by the kidneys are sensitive to kidney function; impaired renal clearance lets them accumulate to concentrations that a healthy individual would not reach at the same dose.
Genetic variation in enzyme genes — particularly CYP2D6 and CYP2C19 — creates meaningful differences in clearance between individuals. Someone who metabolises a drug unusually fast may experience weaker or shorter effects; someone who metabolises it slowly may experience prolonged or intensified effects from an identical dose.
Relevance to substances & effects
Clearance shapes practically every pharmacological outcome a person notices. How long effects last, how quickly they taper, and how a substance behaves across repeated doses all follow directly from how fast the body removes it.
Substances with low clearance — many benzodiazepines, long-acting opioids, certain cannabis metabolites — accumulate with repeated dosing. Effects from the second or third dose can be noticeably stronger or more prolonged than the first suggested, which is one mechanism behind unintentional dose-stacking in these classes.
Clearance is also why drug interactions are taken seriously. When two substances compete for the same metabolic enzymes, each can slow the other's clearance, pushing both toward concentrations that neither would reach alone. Throughout this encyclopedia, the interaction layer notes which combinations carry this risk — clearance interference is one of the primary reasons those flags exist.
AI-generated · not yet verified by a human reviewer
Harm-reduction reference — not medical advice.